1
|
Bhatt DL: CABG the clear choice for
patients with diabetes and multivessel disease. Lancet.
391:913–914. 2018.PubMed/NCBI View Article : Google Scholar
|
2
|
Collet C, Capodanno D, Onuma Y, Banning A,
Stone GW, Taggart DP, Sabik J and Serruys PW: Left main coronary
artery disease: Pathophysiology, diagnosis, and treatment. Nat Rev
Cardiol. 15:321–331. 2018.PubMed/NCBI View Article : Google Scholar
|
3
|
Caliskan E, de Souza DR, Böning A,
Liakopoulos OJ, Choi YH, Pepper J, Gibson CM, Perrault LP, Wolf RK,
Kim KB and Emmert MY: Saphenous vein grafts in contemporary
coronary artery bypass graft surgery. Nat Rev Cardiol. 17:155–169.
2020.PubMed/NCBI View Article : Google Scholar
|
4
|
Aranki SF and Tatooles AJ: Disconnect
between vein graft failure and clinical events after coronary
artery bypass graft surgery. Circulation. 130:1439–1441.
2014.PubMed/NCBI View Article : Google Scholar
|
5
|
de Vries MR, Simons KH, Jukema JW, Braun J
and Quax PH: Vein graft failure: From pathophysiology to clinical
outcomes. Nat Rev Cardiol. 13:451–470. 2016.PubMed/NCBI View Article : Google Scholar
|
6
|
Petrie MC, Jhund PS, She L, Adlbrecht C,
Doenst T, Panza JA, Hill JA, Lee KL, Rouleau JL, Prior DL, et al:
Ten-Year outcomes after coronary artery bypass grafting according
to age in patients with heart failure and left ventricular systolic
dysfunction: An analysis of the extended Follow-Up of the STICH
trial (surgical treatment for ischemic heart failure). Circulation.
134:1314–1324. 2016.PubMed/NCBI View Article : Google Scholar
|
7
|
Escaned J: Secondary revascularization
after CABG surgery. Nat Rev Cardiol. 9:540–549. 2012.PubMed/NCBI View Article : Google Scholar
|
8
|
Lenzen MJ, Boersma E, Bertrand ME, Maier
W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere
P, et al: Management and outcome of patients with established
coronary artery disease: The Euro Heart Survey on coronary
revascularization. Eur Heart J. 26:1169–1179. 2005.PubMed/NCBI View Article : Google Scholar
|
9
|
Brilakis ES, Rao SV, Banerjee S, Goldman
S, Shunk KA, Holmes DR Jr, Honeycutt E and Roe MT: Percutaneous
coronary intervention in native arteries versus bypass grafts in
prior coronary artery bypass grafting patients: A report from the
National Cardiovascular Data Registry. JACC Cardiovasc Interv.
4:844–850. 2011.PubMed/NCBI View Article : Google Scholar
|
10
|
Harskamp RE, Alexander JH, Schulte PJ,
Brophy CM, Mack MJ, Peterson ED, Williams JB, Gibson CM, Califf RM,
Kouchoukos NT, et al: Vein graft preservation solutions, patency,
and outcomes after coronary artery bypass graft surgery: Follow-up
from the PREVENT IV randomized clinical trial. JAMA Surg.
149:798–805. 2014.PubMed/NCBI View Article : Google Scholar
|
11
|
Fiedler J, Baker AH, Dimmeler S, Heymans
S, Mayr M and Thum T: Non-coding RNAs in vascular disease-from
basic science to clinical applications: Scientific update from the
Working Group of Myocardial Function of the European Society of
Cardiology. Cardiovasc Res. 114:1281–1286. 2018.PubMed/NCBI View Article : Google Scholar
|
12
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016.PubMed/NCBI View Article : Google Scholar
|
13
|
Halushka PV, Goodwin AJ and Halushka MK:
Opportunities for microRNAs in the crowded field of cardiovascular
biomarkers. Annu Rev Pathol. 14:211–238. 2019.PubMed/NCBI View Article : Google Scholar
|
14
|
Wang XW, He XJ, Lee KC, Huang C, Hu JB,
Zhou R, Xiang XY, Feng B and Lu ZQ: MicroRNA-221 sponge therapy
attenuates neointimal hyperplasia and improves blood flows in vein
grafts. Int J Cardiol. 208:79–86. 2016.PubMed/NCBI View Article : Google Scholar
|
15
|
Garber JC, Barbee RW, Bielitzki JT,
Clayton LA, Donovan JC, Hendriksen CF, Kohn DF, Lipman NS, Locke
PA, Melcher J, et al: Guide for the Care and Use of Laboratory
Animals. 8th edition. National Research Council of The National
Academies, Washington, DC, 2011.
|
16
|
Kuleshov MV, Jones MR, Rouillard AD,
Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM,
Lachmann A, et al: Enrichr: A comprehensive gene set enrichment
analysis web server 2016 update. Nucleic Acids Res. 44:W90–W97.
2016.PubMed/NCBI View Article : Google Scholar
|
17
|
Lucaciu O, Băciuţ M, Băciuţ G, Câmpian RS
and Ionel A: The Gephi Network visualisation of the guided bone
regeneration process induced with tissue engineered grafts. In: Key
Engineering Materials. Trans Tech Publ. 695:215–221. 2016.
|
18
|
Zhao Y, Tang N, Xi D, Huang Z, Zhang T,
Liu Y, Wang L, Tang Y, Zhong H and He F: Calcilytic NPS2143
promotes proliferation and inhibits apoptosis of spontaneously
hypertensive rat vascular smooth muscle cells via activation of the
renin-angiotensin system. Exp Ther Med. 20:818–829. 2020.PubMed/NCBI View Article : Google Scholar
|
19
|
Feng X, Liu P, Zhou X, Li MT, Li FL, Wang
Z, Meng Z, Sun YP, Yu Y, Xiong Y, et al: Thromboxane A2 Activates
YAP/TAZ protein to induce vascular smooth muscle cell proliferation
and migration. J Biol Chem. 291:18947–18958. 2016.PubMed/NCBI View Article : Google Scholar
|
20
|
Simo-Cheyou ER, Vardatsikos G and
Srivastava AK: Src tyrosine kinase mediates endothelin-1-induced
early growth response protein-1 expression via MAP kinase-dependent
pathways in vascular smooth muscle cells. Int J Mol Med.
38:1879–1886. 2016.PubMed/NCBI View Article : Google Scholar
|
21
|
Thiel G, Mayer SI, Müller I, Stefano L and
Rössler OG: Egr-1-A Ca(2+)-regulated transcription factor. Cell
Calcium. 47:397–403. 2010.PubMed/NCBI View Article : Google Scholar
|
22
|
Beneit N, Martín-Ventura JL, Rubio-Longás
C, Escribano Ó, García-Gómez G, Fernández S, Sesti G, Hribal ML,
Egido J, Gómez-Hernández A and Benito M: Potential role of insulin
receptor isoforms and IGF receptors in plaque instability of human
and experimental atherosclerosis. Cardiovasc Diabetol.
17(31)2018.PubMed/NCBI View Article : Google Scholar
|
23
|
Wang Z and Yan X: CD146, a
multi-functional molecule beyond adhesion. Cancer Lett.
330:150–162. 2013.PubMed/NCBI View Article : Google Scholar
|
24
|
Jiang T, Zhuang J, Duan H, Luo Y, Zeng Q,
Fan K, Yan H, Lu D, Ye Z, Hao J, et al: CD146 is a coreceptor for
VEGFR-2 in tumor angiogenesis. Blood. 120:2330–2339.
2012.PubMed/NCBI View Article : Google Scholar
|
25
|
Colomb F, Wang W, Simpson D, Zafar M,
Beynon R, Rhodes JM and Yu LG: Galectin-3 interacts with the
cell-surface glycoprotein CD146 (MCAM, MUC18) and induces secretion
of metastasis-promoting cytokines from vascular endothelial cells.
J Biol Chem. 292:8381–8389. 2017.PubMed/NCBI View Article : Google Scholar
|
26
|
Luo Y, Duan H, Qian Y, Feng L, Wu Z, Wang
F, Feng J, Yang D, Qin Z and Yan X: Macrophagic CD146 promotes foam
cell formation and retention during atherosclerosis. Cell Res.
27:352–372. 2017.PubMed/NCBI View Article : Google Scholar
|
27
|
Xie Y, Ostriker AC, Jin Y, Hu H, Sizer AJ,
Peng G, Morris AH, Ryu C, Herzog EL, Kyriakides T, et al: LMO7 is a
negative feedback regulator of transforming growth factor β
signaling and fibrosis. Circulation. 139:679–693. 2019.PubMed/NCBI View Article : Google Scholar
|
28
|
Cooley BC, Nevado J, Mellad J, Yang D, St
Hilaire C, Negro A, Fang F, Chen G, San H, Walts AD, et al: TGF-β
signaling mediates endothelial-to-mesenchymal transition (EndMT)
during vein graft remodeling. Sci Transl Med.
6(227ra234)2014.PubMed/NCBI View Article : Google Scholar
|
29
|
Greer P: Closing in on the biological
functions of Fps/Fes and Fer. Nat Rev Mol Cell Biol. 3:278–289.
2002.PubMed/NCBI View
Article : Google Scholar
|
30
|
He J, Bao Q, Yan M, Liang J, Zhu Y, Wang C
and Ai D: The role of Hippo/yes-associated protein signalling in
vascular remodelling associated with cardiovascular disease. Br J
Pharmacol. 175:1354–1361. 2018.PubMed/NCBI View Article : Google Scholar
|
31
|
Ono H, Ichiki T, Ohtsubo H, Fukuyama K,
Imayama I, Hashiguchi Y, Sadoshima J and Sunagawa K: Critical role
of Mst1 in vascular remodeling after injury. Arterioscler Thromb
Vasc Biol. 25:1871–1876. 2005.PubMed/NCBI View Article : Google Scholar
|
32
|
Wang X, Hu G, Gao X, Wang Y, Zhang W,
Harmon EY, Zhi X, Xu Z, Lennartz MR, Barroso M, et al: The
induction of yes-associated protein expression after arterial
injury is crucial for smooth muscle phenotypic modulation and
neointima formation. Arterioscler Thromb Vasc Bio. 32:2662–2669.
2012.PubMed/NCBI View Article : Google Scholar
|
33
|
Wu G, Cai J, Han Y, Chen J, Huang ZP, Chen
C, Cai Y, Huang H, Yang Y, Liu Y, et al: LincRNA-p21 regulates
neointima formation, vascular smooth muscle cell proliferation,
apoptosis, and atherosclerosis by enhancing p53 activity.
Circulation. 130:1452–1465. 2014.PubMed/NCBI View Article : Google Scholar
|
34
|
Wang Z, Zhang XJ, Ji YX, Zhang P, Deng KQ,
Gong J, Ren S, Wang X, Chen I, Wang H, et al: The long noncoding
RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy.
Nat Med. 22:1131–1139. 2016.PubMed/NCBI View
Article : Google Scholar
|
35
|
Yahagi K, Kolodgie FD, Otsuka F, Finn AV,
Davis HR, Joner M and Virmani R: Pathophysiology of native
coronary, vein graft, and in-stent atherosclerosis. Nat Rev
Cardiol. 13:79–98. 2016.PubMed/NCBI View Article : Google Scholar
|
36
|
Storey RF: Exploring mechanisms of graft
occlusion toward improved outcomes in coronary artery bypass graft
surgery. J Am Coll Cardiol. 57:1078–1080. 2011.PubMed/NCBI View Article : Google Scholar
|
37
|
Jelaković B, Nikolić J, Radovanović Z,
Nortier J, Cosyns JP, Grollman AP, Bašić-Jukić N, Belicza M, Bukvić
D, Čavaljuga S, et al: Consensus statement on screening, diagnosis,
classification and treatment of endemic (Balkan) nephropathy.
Nephrol Dial Transplant. 29:2020–2027. 2014.PubMed/NCBI View Article : Google Scholar
|
38
|
Sabik JF II: Understanding saphenous vein
graft patency. Circulation. 124:273–275. 2011.PubMed/NCBI View Article : Google Scholar
|
39
|
Lee R, Margaritis M, Channon KM and
Antoniades C: Evaluating oxidative stress in human cardiovascular
disease: Methodological aspects and considerations. Curr Med Chem.
19:2504–2520. 2012.PubMed/NCBI View Article : Google Scholar
|
40
|
Tóth A, Balogh E and Jeney V: Regulation
of vascular calcification by reactive oxygen species. Antioxidants
(Basel). 9(963)2020.PubMed/NCBI View Article : Google Scholar
|
41
|
Muslin AJ: MAPK signalling in
cardiovascular health and disease: Molecular mechanisms and
therapeutic targets. Clin Sci (Lond). 115:203–218. 2008.PubMed/NCBI View Article : Google Scholar
|
42
|
Garcia JG, Liu F, Verin AD, Birukova A,
Dechert MA, Gerthoffer WT, Bamberg JR and English D: Sphingosine
1-phosphate promotes endothelial cell barrier integrity by
Edg-dependent cytoskeletal rearrangement. J Clin Invest.
108:689–701. 2001.PubMed/NCBI View Article : Google Scholar
|
43
|
Ullrich A, Gray A, Tam AW, Yang-Feng T,
Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, et
al: Insulin-like growth factor I receptor primary structure:
Comparison with insulin receptor suggests structural determinants
that define functional specificity. EMBO J. 5:2503–2512.
1986.PubMed/NCBI
|